Cutera (CUTRQ) Stock Price
Cutera Price
Revenue has compounded at 7.6% per year over the past 19 years to 212.37 M USD. Earnings per share have declined at 4.9% per year over the last 17 years. Cutera's net margin stands at -76.7%, down from -6.8% several years earlier.
Cutera stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Cutera over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cutera stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cutera's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Cutera Price |
|---|
Cutera Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Cutera Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.00 | 77.00 | 74.00 | 78.00 | 94.00 | 118.00 | 151.00 | 162.00 | 181.00 | 147.00 | 231.00 | 252.00 | 212.00 | 145.00 | 152.00 | 170.00 |
| 13.21 | 28.33 | -3.90 | 5.41 | 20.51 | 25.53 | 27.97 | 7.28 | 11.73 | -18.78 | 57.14 | 9.09 | -15.87 | -31.60 | 4.83 | 11.84 |
| 56.67 | 53.25 | 55.41 | 55.13 | 57.45 | 57.63 | 56.95 | 49.38 | 54.14 | 51.02 | 57.58 | 55.16 | 19.34 | 19.34 | 19.34 | 19.34 |
| 34.00 | 41.00 | 41.00 | 43.00 | 54.00 | 68.00 | 86.00 | 80.00 | 98.00 | 75.00 | 133.00 | 139.00 | 41.00 | 28.04 | 29.40 | 32.88 |
| -10.00 | -6.00 | -5.00 | -10.00 | -4.00 | 2.00 | 7.00 | -13.00 | -12.00 | -22.00 | 2.00 | -38.00 | -156.00 | -95.00 | -64.00 | -46.00 |
| -16.67 | -7.79 | -6.76 | -12.82 | -4.26 | 1.69 | 4.64 | -8.02 | -6.63 | -14.97 | 0.87 | -15.08 | -73.58 | -65.52 | -42.11 | -27.06 |
| -10.00 | -6.00 | -4.00 | -10.00 | -4.00 | 2.00 | 30.00 | -30.00 | -12.00 | -23.00 | 2.00 | -82.00 | -162.00 | -104.00 | -67.00 | -53.00 |
| – | -40.00 | -33.33 | 150.00 | -60.00 | -150.00 | 1,400.00 | -200.00 | -60.00 | 91.67 | -108.70 | -4,200.00 | 97.56 | -35.80 | -35.58 | -20.90 |
| 13.80 | 14.10 | 14.40 | 14.30 | 14.00 | 13.80 | 14.70 | 13.80 | 14.10 | 16.70 | 18.40 | 18.70 | 19.89 | 19.89 | 19.89 | 19.89 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Cutera generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cutera retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cutera's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Cutera has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cutera's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Cutera stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Cutera Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Cutera business model & stock analysis
Cutera SWOT Analysis
Strengths
1. Strong market presence and reputation in the medical aesthetics industry.
2. Diverse product portfolio including innovative laser and energy-based devices.
3. Strategic partnerships and collaborations with key industry players.
Weaknesses
1. Relatively high product pricing limits access to certain customer segments.
2. Dependence on a limited number of distributor channels for sales.
3. Limited brand awareness compared to some competitors.
Opportunities
1. Growing demand for non-surgical cosmetic procedures and aesthetics treatments.
2. Expansion into emerging markets with rising disposable incomes.
3. Development of new technological advancements in laser-based treatments.
Threats
1. Intense competition from other established players in the medical aesthetics market.
2. Potential regulatory changes impacting the industry's marketing and sales practices.
3. Economic uncertainties and fluctuations that may affect consumer spending on aesthetic procedures.
Cutera Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Cutera historical P/E ratio, EBIT multiple, and P/S ratio
Cutera annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Cutera shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
EESG©
Eulerpool ESG Scorecard© for the Cutera stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Cutera shareholder structure
| % | Name |
|---|---|
0.38245% | |
0.05290% | |
0.03174% | |
0.00000% | |
0.00000% | |
0.00000% |
Cutera Executives and Management Board
8 members · avg. age 58 · 13 % women
Mr. Taylor Harris (49)
Chief Executive Officer, Director · since 2023
7.28 M USD
Management
Mr. Stuart Drummond (58)
Interim Chief Financial Officer
Mr. Jeffrey Jones (69)
Chief Operating Officer
Dr. Stephana Patton
Chief Legal Officer
Board of Directors
Mr. Kevin Cameron (55)
Chairman of the Board · since 2023
Mr. Nicholas Lewin (47)
Independent Director
Mr. Keith Sullivan (67)
Independent Director
Mr. Paul Wierbicki
Director
Frequently asked questions about Cutera
The business model of Cutera Inc. is focused on the development, manufacture, and marketing of medical aesthetic platforms and products. The company provides innovative technologies and solutions for various aesthetic procedures, including laser hair removal, skin revitalization, and body contouring. Cutera Inc. aims to enhance the confidence and well-being of individuals through its advanced aesthetic systems. With a strong commitment to research and development, Cutera Inc. continually strives to deliver safe and effective solutions to professionals in the aesthetics industry.
Cutera Inc is primarily active in the medical aesthetics industry, specializing in the development and manufacture of laser and other energy-based devices for aesthetic procedures. Their advanced technologies are used in various medical practices, including plastic surgery, dermatology, and cosmetic surgery. Cutera Inc's commitment to innovation and providing effective solutions has made them a leading player in the aesthetic medical device market. With a strong focus on delivering safe and proven results, Cutera Inc has gained prominence as a trusted name in the field of medical aesthetics.
Some of the main competitors of Cutera Inc in the market include Cynosure, Syneron Medical Ltd, and Lumenis Ltd. These companies also specialize in medical aesthetics and offer a range of similar products and services to Cutera Inc. However, Cutera Inc is known for its unique and innovative approach, distinguishing itself from competitors through its advanced technologies and customer-oriented solutions.
Cutera Inc. is a leading provider of energy-based medical aesthetic technologies. Established in 1998, the company has a rich history of innovation and expertise in the field of laser and energy-based devices for dermatology, aesthetics, and other medical specialties. Cutera is renowned for its advanced technologies, including its flagship excel V™ laser system for vascular and pigmented lesions. With a strong commitment to research and development, Cutera continues to introduce groundbreaking solutions that help medical professionals enhance patient outcomes. Headquartered in Brisbane, California, Cutera Inc. operates globally and remains at the forefront of the evolving aesthetics industry.
Cutera Inc has achieved several significant milestones throughout its history. One notable milestone was the development of their groundbreaking laser and energy-based aesthetic systems, which have revolutionized the medical aesthetics industry. Another milestone was the company's successful expansion into international markets, establishing a strong global presence. Cutera Inc also achieved notable clinical advancements, such as the introduction of innovative technologies for skin rejuvenation and hair removal. The company has consistently focused on research and development, resulting in numerous FDA clearances and patents. These achievements have solidified Cutera Inc's position as a leader in the industry, constantly pushing boundaries and delivering innovative solutions to their customers.
Cutera Inc is primarily present in various countries and regions around the world. The company operates in North America, including the United States and Canada, where it has a significant presence. Additionally, Cutera Inc has a strong presence in Europe, including countries like Germany, France, and the United Kingdom. Furthermore, the company has established its market in the Asia-Pacific region, specifically in countries such as Japan, China, and Australia. With its global reach, Cutera Inc caters to a diverse customer base across different continents, making it a prominent player in the international stock market.
Cutera Inc represents a commitment to innovation, results-driven technology, and exceptional patient care. With a strong corporate philosophy focused on helping individuals enhance their self-confidence and well-being, Cutera Inc strives to provide advanced aesthetic solutions. The company's values encompass integrity, collaboration, and customer satisfaction. By utilizing cutting-edge technology and continuously investing in research and development, Cutera Inc aims to deliver safe and effective aesthetic procedures to its global clientele. With a strong emphasis on quality and innovation, Cutera Inc sets itself apart as a leading provider in the aesthetics industry.
11 analysts currently rate the Cutera stock: 8 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Cutera to generate revenue of 170.63 M USD and earnings per share of -2.69 USD.
Converted at the current exchange rate, the Cutera share trades at 0.01 EUR (0.01 USD).
The Cutera share (CUTRQ) is listed on 3 stock exchanges, including: NASDAQ (CUTR), Frankfurt (TJ9.F), Düsseldorf (TJ9.DU).
Cutera Inc is a leading company in the field of aesthetic laser technologies. The company was founded in 1998 and is headquartered in California, USA. Cutera offers its customers laser and light-based solutions to improve the skin and body. Cutera's business model encompasses various sectors such as medicine and beauty. Cutera focuses on developing products and devices that have a wide range of applications in aesthetic and medical dermatology. Cutera's products include a variety of laser systems that can be used for different applications. The laser systems are used in both medical dermatology and aesthetic dermatology. Cutera's medical devices are highly precise and can reach the deepest layers of the skin. They are used in the treatment of various skin conditions and disorders. The company also offers products that can be used in the cosmetics and wellness industry. One example of Cutera's products is the xeo® laser system. It is a versatile system that has a wide range of applications, including hair removal, wrinkle reduction, acne treatment, pigmentation, vascular lesion removal, and body contouring. The xeo® laser system uses the latest technology to ensure the highest performance and precision in treatment. Another product from Cutera is the Excel V+ laser system. It is a powerful device used in the treatment of vascular lesions and pigmentation. The system is also capable of treating redness and rosacea and can improve skin color and texture. The Excel V+ laser system is able to perform very precise and efficient treatments, making it highly valued in dermatological treatment. Cutera operates a global business and its products are sold worldwide. The company has distribution partnerships in North America, Europe, Asia (including China), and Australia. Cutera's business model is based on selling medical and aesthetic laser systems, as well as selling accessories and medical devices. Cutera's customers are doctors, medical facilities, and beauty studios. Cutera also has strong customer loyalty and offers a wide range of training and support services to ensure that customers can make the most of their products. The company organizes seminars and training sessions to educate customers on product use and facilitate handling any difficulties. Cutera has a highly effective business model based on the development of innovative products. The company has a strong presence in the market for aesthetic laser technologies and medical devices, and its products are used worldwide. The business model is based on a strong distribution network and excellent customer support. Cutera will continue to invest in the development of innovative products and expand its presence in the global market in the future.
The expected revenue of Cutera is 170.63 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cutera is -53.44 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cutera is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cutera stock.
The price-to-sales ratio (P/S) of Cutera is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cutera stock.
The Eulerpool Quality Score for Cutera is 3/10.
The ISIN of Cutera is US2321091082. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Cutera is A0B9QG. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Cutera is CUTRQ. The ticker symbol is used to trade Cutera shares on the stock exchange.
Cutera paid dividends every year for the past 0 years.
Cutera is assigned to the 'Health' sector.
The dividends of Cutera are distributed in USD.
Cutera stock
Cutera Peer Group
Cutera Ticker
Cutera FIGI
All fundamentals and in-depth analysis of Cutera
Our stock analysis for Cutera stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cutera. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.